ArticleBMC pulmonary medicine2026
Patterns of bronchoalveolar lavage in fibrotic and non-fibrotic interstitial lung diseases - a multicenter analysis.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchoalveolar lavage (BAL) cellular analysis is recommended as part of the diagnostic workup of interstitial lung diseases (ILD) when diagnosis is unclear. In recent years, ILD have been classified based on the presence or absence of fibrosis. The objective of this study was to compare BAL cellular profiles across multiple ILDs, stratified by fibrosis status.
methodsA retrospective multicenter study of consecutive patients who underwent bronchoscopy, including BAL for ILD evaluation, between 2017 and 2022. BAL indices were chosen based on guidelines and prior research. Chest radiologists blinded to clinical data performed radiological assessment. ILD diagnoses were assigned by multi-disciplinary discussion.
resultsIn total, 238 patients with BAL results were included (mean age 60 years, 46% females, 50.4% with fibrotic ILD, 91% with concurrent transbronchial biopsy). BAL lymphocytes > 20% and > 30% were more prevalent in non-fibrotic compared to fibrotic ILD (36.4% vs. 17.5% and 25.4% vs. 9.2%, p < 0.01). In multivariate linear regression model, fibrotic disease was associated with lower lymphocyte counts (β=-6.15, p = 0.007). Rates of mixed BAL pattern, lymphocytosis, or isolated neutrophils > 3% did not distinguish between fibrotic diseases. On computed tomography, BAL lymphocytosis was not associated with ground-glass opacities or mosaic attenuation in both fibrotic and non-fibrotic groups, while honeycombing was associated with a lower rate of elevated (> 4.5%) BAL neutrophils (71% vs. 91%, p = 0.018).
conclusionSpecific patterns in BAL differential were uncommon in fibrotic ILD and were not different among its subtypes. As a stand-alone modality, BAL seems to have a limited utility in fibrotic ILD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.